Matt S. Anderson

3.9k total citations
70 papers, 3.1k citations indexed

About

Matt S. Anderson is a scholar working on Molecular Biology, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matt S. Anderson has authored 70 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Infectious Diseases and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matt S. Anderson's work include HIV/AIDS drug development and treatment (13 papers), Glycosylation and Glycoproteins Research (11 papers) and Migraine and Headache Studies (8 papers). Matt S. Anderson is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), Glycosylation and Glycoproteins Research (11 papers) and Migraine and Headache Studies (8 papers). Matt S. Anderson collaborates with scholars based in United States, Belgium and Germany. Matt S. Anderson's co-authors include Christian R.H. Raetz, Suzanne S. Eveland, C R Raetz, Sheryl A. Hyland, Theresa M. Kelly, Hiroshi Ōnishi, Lynn L. Silver, David L. Pompliano, Susan Galloway and John A. Wagner and has published in prestigious journals such as Science, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Matt S. Anderson

68 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matt S. Anderson United States 32 1.5k 703 493 400 356 70 3.1k
John F. Barrett United States 39 2.5k 1.6× 369 0.5× 884 1.8× 603 1.5× 565 1.6× 122 4.9k
Bong‐Jin Lee South Korea 32 2.0k 1.3× 479 0.7× 229 0.5× 236 0.6× 249 0.7× 185 4.0k
K.P. Battaile United States 34 2.1k 1.3× 527 0.7× 232 0.5× 739 1.8× 95 0.3× 131 3.6k
Matthew W. Frank United States 30 1.7k 1.1× 419 0.6× 114 0.2× 444 1.1× 257 0.7× 63 2.9k
Nicholas Murgolo United States 30 1.8k 1.1× 299 0.4× 165 0.3× 567 1.4× 374 1.1× 64 4.3k
Young Ho Jeon South Korea 31 2.6k 1.7× 423 0.6× 296 0.6× 107 0.3× 122 0.3× 124 3.5k
Matthias Wittwer Switzerland 33 1.2k 0.8× 370 0.5× 206 0.4× 321 0.8× 118 0.3× 87 3.0k
Sujata Sharma India 27 1.4k 0.9× 505 0.7× 175 0.4× 358 0.9× 137 0.4× 81 2.8k
Jinn‐Moon Yang Taiwan 32 2.3k 1.5× 244 0.3× 568 1.2× 358 0.9× 45 0.1× 157 4.3k
Jason H. Yang United States 21 1.7k 1.1× 546 0.8× 119 0.2× 412 1.0× 935 2.6× 43 3.2k

Countries citing papers authored by Matt S. Anderson

Since Specialization
Citations

This map shows the geographic impact of Matt S. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt S. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt S. Anderson more than expected).

Fields of papers citing papers by Matt S. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt S. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt S. Anderson. The network helps show where Matt S. Anderson may publish in the future.

Co-authorship network of co-authors of Matt S. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Matt S. Anderson. A scholar is included among the top collaborators of Matt S. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt S. Anderson. Matt S. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhardwaj, Rajinder, Jennifer Madonia, Kyle Matschke, et al.. (2024). Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo‐controlled study in healthy adults. Headache The Journal of Head and Face Pain. 65(2). 315–325. 5 indexed citations
2.
Bhardwaj, Rajinder, Jennifer Madonia, Matt S. Anderson, et al.. (2024). Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects. Clinical and Translational Science. 17(10). e70015–e70015. 4 indexed citations
3.
Bhardwaj, Rajinder, Jennifer Madonia, Matt S. Anderson, et al.. (2024). Deconvoluting zavegepant drug–drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics. Clinical and Translational Science. 17(12). e70048–e70048. 1 indexed citations
4.
Masdeu, Joseph C., Belén Pascual, Paolo Zanotti‐Fregonara, et al.. (2020). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (2640). Neurology. 94(15_supplement). 4 indexed citations
5.
Yee, Ka Lai, Sauzanne Khalilieh, Rosa I. Sánchez, et al.. (2017). The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects. Clinical Drug Investigation. 37(7). 659–667. 40 indexed citations
6.
Anderson, Matt S., Sauzanne Khalilieh, Ka Lai Yee, et al.. (2016). A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir. Clinical Pharmacokinetics. 56(6). 661–669. 25 indexed citations
7.
Lohith, Talakad G., Paul McQuade, Cristian Salinas, et al.. (2016). First-in-human PET imaging of mGluR2 receptors.. 57. 213–213. 9 indexed citations
8.
Anderson, Matt S., Josée Côté, Yang Liu, et al.. (2013). Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib. The Journal of Clinical Pharmacology. 53(7). 746–752. 14 indexed citations
9.
Krauss, Ronald M., Cathy Anne Pinto, Yang Liu, et al.. (2011). Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib. Journal of Lipid Research. 53(3). 540–547. 69 indexed citations
10.
Sweis, Ramzi F., Julianne A. Hunt, Peter M. Sinclair, et al.. (2011). 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Attenuation of hERG binding and improved HDLc-raising efficacy. Bioorganic & Medicinal Chemistry Letters. 21(9). 2597–2600. 11 indexed citations
11.
Lu, Zhijian, Ashleigh B. Theberge, Amjad Ali, et al.. (2010). Design of a novel class of biphenyl CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7469–7472. 11 indexed citations
12.
Anderson, Matt S., William D. Hanley, Bo Jin, et al.. (2010). Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women. British Journal of Clinical Pharmacology. 71(4). 616–620. 18 indexed citations
13.
Anderson, Matt S., William D. Hanley, Bo Jin, et al.. (2010). Effect of Raltegravir on the Pharmacokinetics of Methadone. The Journal of Clinical Pharmacology. 50(12). 1461–1466. 8 indexed citations
14.
Anderson, Matt S.. (2008). Pharmacokinetic (PK) Evaluation of Darunavir/Ritonavir (DRV/r) and Raltegravir (RAL) in Healthy Subjects. 46th Annual Meeting. 5 indexed citations
15.
Boice, Judith A., et al.. (2001). An ex vivo angiogenesis assay utilizing commercial porcine carotidartery: Modification of the rat aortic ring assay. Angiogenesis. 4(1). 3–9. 37 indexed citations
16.
Young, Katherine, Lynn L. Silver, David Bramhill, et al.. (1995). The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis. Journal of Biological Chemistry. 270(51). 30384–30391. 157 indexed citations
17.
Kelly, Theresa M., et al.. (1993). The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis.. Journal of Biological Chemistry. 268(26). 19866–19874. 112 indexed citations
18.
19.
20.
Maycock, Alan L., et al.. (1982). Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4.. Journal of Biological Chemistry. 257(23). 13911–13914. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John F. Barrett Breakdown of academic impact, for papers by Bong‐Jin Lee Breakdown of academic impact, for papers by K.P. Battaile Breakdown of academic impact, for papers by Matthew W. Frank Breakdown of academic impact, for papers by Nicholas Murgolo Breakdown of academic impact, for papers by Young Ho Jeon Breakdown of academic impact, for papers by Matthias Wittwer Breakdown of academic impact, for papers by Sujata Sharma Breakdown of academic impact, for papers by Jinn‐Moon Yang Breakdown of academic impact, for papers by Jason H. Yang
Rankless by CCL
2026